This article is freely available to all

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: The 2002 National Institutes of Health Consensus Development Conference recommended that treatments for hepatitis C virus (HCV) be extended to groups previously thought to be high-risk candidates for receiving interferon treatment. These high-risk groups include those with severe and persistent mental illnesses such as bipolar disorder.1 Interferon is known for inducing or causing relapse to depression.’ ‹